By NewsDesk @bactiman63
In a statement Friday from Susan R. Bailey, M.D., President, American Medical Association (AMA), she says the following:
“For much of this year, physicians, nurses and frontline health care personnel have done herculean, unprecedented work to care for patients and prevent the spread of COVID-19 – all while scientists and researchers sprinted to develop a safe and effective vaccine. After a thorough, rigorous, transparent review process, today’s decision by the FDA to grant an Emergency Use Authorization (EUA) for the first COVID-19 vaccine developed by Pfizer and BioNTech is a monumental milestone with the potential to set us on a road to recovery. The comprehensive, science-based, transparent nature of this process is critical to inspiring the public’s confidence in this vaccine.
“We now look forward to the Advisory Committee on Immunization Practices’ (ACIP) open deliberations and their recommendations to the CDC Director for use of the vaccine in the US population to control COVID-19.”
- Researchers evaluate face masks and coverings as protection against COVID-19
- Philippines COVID-19 update: Christmas with no karaoke singing, DOH recommends face masks for gifts
- Nevada: Gonorrhea case with mosaic penA60 allele identified, First in the US
- Yellow fever: More monkey deaths in Paraná state
- Canada: COVID-19 outbreak at a mink farm in the Fraser Valley, British Columbia
- Europe: More than 500 avian influenza detections, Most in Germany
- India: Plasmodium ovale malaria reported in Kerala, Found in soldier returning from Africa
- Canada approves Pfizer COVID-19 vaccine
